Friday, November 27, 2015 2:28:15 PM
For now all we know is what can be accessed from other public records and IFUS facebook updates on the Bagasse operations, and easy to find (Google them) distributors of IFUS Intact Digest (which I have been buying online and taking for over 2 years now) and the other blue line products.
IFUS is not required to report, and under the special rules they switched to, they are not required to report financials. It is however safe to assume that IFUS has not yet made a significant profit to justify filling financials, just yet. Also with zero volume, zero promos, and a stock price flat line on the averages at .06 for 2 years, that is and has been showing no dilution. Nevada corporate registration records and IFUS fillings confirm no change in the IFUS-AS of 350 Mil since 2010. Therefore, IFUS must be generating enough profit to pay all the legal harassment lawsuit costs and the counter-suit costs for torturous interference and theft of IFUS property by ex-IFUS-SE directors, and the other daily operating costs as the CEO builds the business with out further dilution. IFUS must file several forms to raise the AS and issue any new shares.
Hope that helps.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM